Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR1 |
Variant | R189C |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | FGFR1 R189C lies within Ig-like C2-type domain 2 of the Fgfr1 protein (UniProt.org). R189C results in an increased growth advantage in a competition assay but transformation activity similar to wild-type Fgfr1 in cultured cells (PMID: 34272467), and therefore, its effect on Fgfr1 protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
FGFR1 mutant FGFR1 R189C |
Transcript | NM_023110.3 |
gDNA | chr8:g.38427977G>A |
cDNA | c.565C>T |
Protein | p.R189C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001174063.2 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
NM_023110.2 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
XM_017013222.2 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
XM_047421570.1 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
XM_006716303.3 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
NM_001174063.1 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
NM_023110.3 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
XM_017013221.2 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
XM_006716303.4 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
XM_006716304.1 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
XM_017013221.1 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
XM_006716304.2 | chr8:g.38427977G>A | c.565C>T | p.R189C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FGFR1 R189C | Advanced Solid Tumor | predicted - sensitive | Fexagratinib | Preclinical - Cell culture | Actionable | In a preclinical study, cells expressing FGFR1 R189C were sensitive to treatment with AZD4547 in culture, demonstrating reduced cell viability (PMID: 34272467). | 34272467 |
FGFR1 R189C | Advanced Solid Tumor | predicted - sensitive | Infigratinib | Preclinical - Cell culture | Actionable | In a preclinical study, cells expressing FGFR1 R189C were sensitive to treatment with Truseltiq (infigratinib) in culture, demonstrating reduced cell viability (PMID: 34272467). | 34272467 |
FGFR1 R189C | Advanced Solid Tumor | predicted - resistant | Dovitinib | Preclinical - Cell culture | Actionable | In a preclinical study, cells expressing FGFR1 R189C were resistant to treatment with Dovitinib (TKI258) in culture (PMID: 34272467). | 34272467 |